Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mazzoni, M. R.
Right arrow Articles by Hamm, H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mazzoni, M. R.
Right arrow Articles by Hamm, H. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 47, Issue of November 22, 1996 pp. 30034-30040
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Interaction of Transducin with Light-activated Rhodopsin Protects It from Proteolytic Digestion by Trypsin*

(Received for publication, August 9, 1996, and in revised form, September 9, 1996)

Maria R. Mazzoni Dagger § and Heidi E. Hamm par

From Dagger  Istituto Policattedra di Discipline Biologiche, University of Pisa, 56126 Pisa, Italy and the  Department of Physiology and Biophysics, University of Illinois at Chicago, Chicago, Illinois 60612

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

The tryptic cleavage pattern of transducin (Gt) in solution was compared with that in the presence of phospholipid vesicles, rod outer segment (ROS) membranes kept in the dark, or ROS membranes containing light-activated rhodopsin, metarhodopsin II (Rh*). When Gt was in the high affinity complex with Rh*, the alpha t subunit was almost completely protected from proteolysis. The protection of alpha t at Arg310 was complete, while Arg204 was substantially protected. The cleavage of alpha t at Lys18 was protected in the presence of phospholipid vesicles, ROS membranes kept in the dark, or ROS membranes containing Rh*. The cleavage of beta t was slower in the presence of ROS membranes or phospholipid vesicles. When the Rh*·Gt complex was incubated with guanyl-5'-yl thiophosphate, a guanine nucleotide analog known to release the high affinity interaction between Gt and Rh*, the protection at Arg310 and Arg204 was diminished. From our results, we propose that Rh* either physically blocks access of trypsin to Arg204 and Arg310 or maintains the heterotrimer in such a conformation that these cleavage sites are not available. Since Arg204 is involved in the switch interface with beta gamma t (Lambright, D. G., Sondek, J., Bohm, A., Skiba, N. P., Hamm, H. E., and Sigler, P. B. (1996) Nature 379, 311-319), it may be that beta gamma t is implicated in protecting this cleavage site in the receptor-bound, stabilized heterotrimer. Arg310 is not near the beta gamma t subunit, thus we believe that the high affinity binding of Gt to Rh* physically or sterically blocks access of trypsin to this site. Thus, Arg310, only a few angstroms away from the carboxyl terminus of alpha t, which is known to directly bind to Rh*, is likely to also be a part of the Rh* binding site. This is in agreement with other studies and has implications for the mechanism by which receptors catalyze GDP release from G proteins. The protection of Lys18 in the presence of phospholipid vesicles suggests that the amino-terminal region is in contact with the membrane, consistent with the crystal structure of the heterotrimer (Lambright, D. G., Sondek, J., Bohm, A., Skiba, N. P., Hamm, H. E., and Sigler, P. B. (1996) Nature 379, 311-319).


INTRODUCTION

Certain extracellular signals, including hormones, neurotransmitters, neuromodulators, chemokines, odorants, and light, activate a class of receptors that initiate cellular effects via activation of heterotrimeric G proteins. Agonist binding to the G protein-coupled receptors leads to conformational changes that promote a tighter interaction with specific G proteins, catalysis of GDP release, and subsequent G protein activation. In the absence of guanine nucleotides, agonist binding to the receptor is stabilized by the bound G protein. The structural basis of the ternary complex among agonist, receptor, and heterotrimeric G protein is an active area of study. Extensive mutagenesis experiments, as well as peptide competition investigations for a variety of G protein-coupled receptors, have led to an understanding that the second and third cytoplasmic loops and, in some circumstances, the putative fourth loop, as well as portions of alpha  helices VI and VII, are important in recognition of cognate G proteins (1, 2, 3). It has been shown that the heterotrimeric G protein, rather than just the alpha  or beta gamma subunits, is required for the interaction, but studies pointing out the importance of specific regions are thus far limited to the alpha  subunits (4, 5, 6, 7).

The crystal structures of the active (GTPgamma S1 and GDP AlF4--bound) (8, 9, 10) and inactive (GDP-bound) (11, 12) forms of the alpha  subunits of transducin (Gt) and Gi1 have been reported. Analysis of the two crystal forms has established the nature of the conformational change induced by the exchange of GTP for GDP and the switch mechanism by which the presence or absence of the gamma -phosphate defines the active or inactive state of the alpha t subunit (9, 11). The high resolution crystal structures of the heterotrimeric G proteins, Gt and Gi1, provide a fundamental context for understanding how a heterotrimer interacts with the membrane and with activated receptors (13, 14). The molecular mechanisms involved in the conformational changes of the alpha  subunit and the nucleotide exchange induced by the heterotrimeric G protein interacting with activated receptors are of great interest. Denker et al. (15) suggested that agonist binding to the receptor initiates the exchange of nucleotide from Go by movement of the alpha o subunit carboxyl-terminal region. The guanine ring of GDP interacts with the residues TCAT, 30 residues from the carboxyl terminus, in a loop at the amino terminus of the final alpha -helix (alpha 5). The receptor-stimulated movement of alpha -helix 5 may allow for the release of GDP. Consistent with this suggestion, disturbing the interactions between the conserved TCAT region of the alpha  subunit and the guanine ring of GDP has been shown to decrease GDP affinity (16, 17).

It has been known for many years that the presence of G proteins increases agonist affinity to receptors, while binding of either GDP or GTP to the G protein complex disrupts the high affinity agonist binding state (18, 19). Thus, one of the primary ways of measuring the ternary complex formed by the agonist, receptor, and G protein, is by analyzing the agonist affinity for the receptor. G protein binding to the light-activated rhodopsin (Rh) receptor induces a high affinity state that can be measured either as decreased ability to remove the G protein from the membrane (20) or as stabilization of the active signaling state of rhodopsin, metarhodopsin II (Rh*) (21, 22). The high affinity state is induced by Rh*-catalyzed loss of GDP, leading to an empty guanine nucleotide binding pocket (23). The addition of either GTP or GDP can promote the loss of the high affinity state, measured by centrifugation (20, 24, 25) or decay of Rh* (23, 26, 27). The mechanisms involved in initiating the allosteric modulation of the agonist binding site on the receptor upon guanine nucleotide binding to the G protein are still unknown.

The studies presented here investigate the following areas: 1) determining the regions on Gt, besides those already implicated, involved in its high affinity interaction with Rh*; 2) elucidation of the conformational changes of Gt induced by the tight interaction with Rh*; and 3) resolving how the conformational changes induced by guanine nucleotide binding to the alpha  subunit decrease the affinity of Gt for Rh* and cause Rh* decay. The tryptic digestion pattern of Gt is well known (28, 29). The GTP-induced conformational switch leads to a changed proteolytic digestion at Arg204, in alpha -helix 2 (28, 30). A proteolytic site at the amino terminus of the alpha t subunit is partially protected by the presence of the beta gamma t subunit (31). In this work, we examine whether the high affinity interaction between Gt and activated rhodopsin (Rh*) affects the alpha t and beta t subunit proteolytic digestion pattern. The effects of phospholipid vesicles (PL), rod outer segment (ROS) membranes kept in the dark, or ROS membranes containing Rh* on tryptic digestion patterns of Gt were investigated. In particular, we focused on the changes in the tryptic digestion pattern and time course of the alpha t subunit induced by Rh* interaction. Our results indicate that the presence of ROS membranes containing Rh, Rh*, or phospholipid vesicles each uniquely affects Gt proteolysis but that interaction with Rh* has the most dramatic effects.


EXPERIMENTAL PROCEDURES

Materials

TPCK-treated trypsin was purchased from Worthington. GDPbeta S and TLCK were products of Boehringer Mannheim. The LumiGLO substrate kit and peroxidase-labeled antibodies to rabbit or mouse IgG were purchased from Kirkegaard and Perry Laboratories, Inc. Fluorescent and standard molecular weight markers were obtained from Sigma. All other chemicals and reagents were of the highest purity available.

Antibodies

Monoclonal antibody 4A was prepared and purified as described by Hamm and Bownds (32) and Witt et al. (33). The alpha  subunit antisera 116, 1398, and 8645 were a generous gift of Dr. D. Manning (Department of Pharmacology, University of Pennsylvania, Philadelphia) (34, 35). Antiserum 116 recognizes the synthetic peptide IKNNLKDCGLF, which corresponds to alpha i1/2-(344-354). This antiserum also recognizes the alpha t subunit (35). Antiserum 1398 recognizes alpha t-(36-47) (GAGESGKSTIVK). Antiserum 8645 recognizes the synthetic peptide FDVGGQRSERKK, which corresponds to alpha t-(195-206).

Western Blotting

SDS-polyacrylamide gel (12.5%) electrophoresis was carried out according to the method of Laemmli (36). Proteins and peptides were electroblotted from the SDS-polyacrylamide gel to nitrocellulose (0.1 µm, Schleicher & Schuell) essentially as described by Towbin et al. (37). After an overnight transfer, the nitrocellulose was examined under UV light to detect the fluorescent molecular weight markers. The nitrocellulose was then incubated in PBS (10 mM NaH2PO4, pH 7.4, 0.9% NaCl), containing 3% lowfat dried milk and 0.2% Tween 20 (PBS/milk) at room temperature. After 30 min, the nitrocellulose was incubated in PBS/milk buffer containing monoclonal antibody 4A (50 µg/ml) or an anti-alpha t antiserum (1:8,000 dilution) for 1 h at room temperature. The immunoblots were washed four times (10 min each) with PBS/milk buffer and incubated in PBS/milk buffer containing peroxidase-labeled second antibody (1:10,000 dilution) for 1 h at room temperature. The washing step was repeated as described above, followed by two washes with PBS and one with distilled water. The immunoblots were incubated in LumiGLO substrate for 1 min at room temperature in the light and then exposed to Kodak XAR-2 film for a few seconds.

For some experiments, the immunoblots were stripped by incubation in stripping buffer (62 mM Tris-HCl, pH 6.5, 100 mM beta -mercaptoethanol, 2% SDS) for 30 min at 50 °C, followed by several washes with PBS.

Phospholipid Vesicles, ROS Membranes, and Gt

Neutral phosphatidylcholine (PC) vesicles were a generous gift of Dr. J. Malinski (Department of Biochemistry, Baylor College of Medicine, Houston). PC vesicles were prepared essentially as described by Kim et al. (38) and resuspended in buffer A (10 mM MOPS, pH 7.5, 200 mM NaCl, 2 mM MgCl2) containing 0.1 mM EDTA. The phospholipid concentration was determined as described (39). In the final vesicle preparation, the total phospholipid concentration was 4.9 mM, which corresponded to that present in ROS membranes containing 82 µM rhodopsin.

Bovine ROS membranes were prepared as described previously (29). ROS membranes stripped with 4 M urea (urea-washed ROS membranes) were prepared as described (40). Aliquots of both ROS membrane preparations were stored in the dark at -80 °C until needed. Rhodopsin concentration was determined by measuring the absorbance of solubilized ROS membrane suspensions at 500 nm before and after bleaching. Gt was extracted from ROS membranes as described previously (29) and stored in 40% glycerol at -20 °C. Gt concentration was determined by the Coomassie Blue binding method (41), using bovine serum albumin as a standard (Pierce).

Proteolysis of Gt

Limited tryptic digestion of Gt in the absence and presence of urea-washed ROS membranes kept in the dark, containing Rh* or PL, was performed essentially as described by Mazzoni et al. (29). Gt was incubated in buffer A (10 mM MOPS, pH 7.5, 200 mM NaCl, 2 mM MgCl2, 1 mM dithiothreitol) with urea-washed ROS membranes either in the dark or light for 10 min at room temperature. The rhodopsin concentration was 36 µM, while the Gt:rhodopsin molar ratio was 1:5. For some experiments performed in ambient light, 100 µM GDPbeta S was present in the buffer throughout the assay. All of the manipulations of samples containing urea-washed ROS membranes kept in the dark were performed under dim red light. After incubation, samples were centrifuged at 13,000 × g for 5 min at room temperature.

Gt (0.55 mg/ml) was similarly incubated in buffer A with PL (2.2 mM PC). The samples containing ROS membranes or PL were centrifuged at 50,000 rpm for 30 min at 4 °C in a Beckman fixed angle TL-100.2 ultracentrifuge rotor. Pellets were resuspended in buffer A containing 25% glycerol at a Gt concentration of 1.6 mg/ml and kept in ice. After removing an aliquot for the control at time 0, trypsin solution (0.06 mg/ml in buffer A containing 25% glycerol) was added. The final concentration of Gt was 0.8 mg/ml, and the trypsin:Gt (w/w) ratio was 1:25. As a control, Gt was subjected to identical treatment in the absence of urea-washed ROS membranes. The reaction was terminated by incubating an aliquot of the reaction mixture with TLCK at a final concentration of 40 µg/ml. After 5 min, 2 × electrophoresis sample buffer (37) was added, and the samples were immediately frozen and stored at -80 °C. Proteolytic fragments were separated by SDS-polyacrylamide (12.5%) gel electrophoresis as described above.

Data Analysis

For both Coomassie Blue-stained gels and immunoblots, the density of polypeptide bands was measured using a Molecular Dynamic densitometer (Personal Densitometer SI). Curve fitting of the data was performed with nonlinear least square criteria using GraphPad Prism software.


RESULTS

The recent determination of the high resolution crystal structure of the heterotrimeric G protein, Gt, provided some indication of the orientation of the molecule with respect to the membrane and the visual receptor rhodopsin. To further understand the structural basis of the high affinity interaction between rhodopsin and Gt we determined the effect of the rhodopsin-Gt complex formation on the accessibility of tryptic cleavage sites on the alpha t and beta t subunits.

The sequential appearance of proteolytic fragments during the time course of Gt-limited tryptic digestion has been widely studied, and the origin of these fragments is well characterized (28, 29, 30) (Fig. 1). As indicated, the alpha t subunit has three regions that are readily available for limited tryptic digestion: Lys18, Arg204, and Arg310. Five transient proteolytic fragments of the alpha t subunit appear (alpha 38, alpha 34, alpha 32, alpha 23, and alpha 15), while the final fragments are alpha 21, alpha 12, alpha 5, and alpha 2 (29). The beta t subunit is rapidly converted to two stable fragments (beta 23 and beta 14) (Fig. 1), while the gamma t subunit remains intact (28). Under nondenaturing conditions, the two tryptic fragments of the beta t subunit and the gamma t subunit remain tightly associated (28).


Fig. 1. Distribution of proteolytic fragments from the alpha t and beta t subunits. The dashed lines represent the cleavage sites available during the limited tryptic digestion of alpha t·GDP and beta t. The number that follows alpha  or beta  indicates the size of the fragment in kilodaltons.
[View Larger Version of this Image (35K GIF file)]


Purified Gt was incubated with PL, ROS membranes containing inactive (Rh), or light-activated rhodopsin (Rh*), and after centrifugation to remove any soluble Gt the membrane fractions were incubated with trypsin. The rate of cleavage was followed for 2 h. Potentially, interaction of Gt with membranes or Rh* could either protect or increase accessibility of known cleavage sites or expose new cleavage sites.

The time course of limited digestion of Gt in the presence and absence of urea-washed ROS membranes is shown in Fig. 2. When soluble Gt was digested with trypsin, the sequential appearance of proteolytic fragments that migrated in the Coomassie Blue-stained polyacrylamide gels with apparent molecular weights of 38, 34, 32, 23, 21, 14, and 12 kDa was evident (Fig. 2A). According to our previous study (29) (Fig. 1) these peptide bands corresponded to five alpha t (alpha 38, alpha 34, alpha 32, alpha 21, and alpha 12) and two beta t fragments (beta 23 and beta 14) A dramatically different result was obtained when Gt was incubated with ROS membranes containing Rh* and allowed to form a high affinity complex. In this complex, the alpha t subunit remained relatively uncleaved during the 2 h of digestion time course (Fig. 2B). To determine whether this protection occurred specifically because of the high affinity interaction with Rh*, parallel experiments were performed using Gt bound to ROS membranes kept in the dark (Fig. 2D) or Gt-Rh* incubated with GDPbeta S, which dissociates the high affinity complex (26, 27) (Fig. 2C). When Gt was in the presence of inactive Rh, the time course of tryptic digestion of alpha t was much more similar to that observed for soluble Gt, while in the presence of Rh* and GDPbeta S, the tryptic pattern was intermediate. Since rhodopsin was also partially cleaved by trypsin, the proteolytic digestion pattern of the alpha t subunit was difficult to analyze in the Coomassie Blue-stained gels due to the presence of numerous peptide bands (Fig. 2) (see below).


Fig. 2. Time course of Gt limited tryptic digestion in the presence and absence of ROS membranes containing Rh, Rh*, or Rh* plus GDPbeta S. Purified bovine Gt (0.54 mg) was incubated in 1 ml of buffer A with urea-washed ROS membranes (33 µM Rh) or membranes plus 100 µM GDPbeta S in the dark or light for 10 min. The samples were centrifuged, and the pellets were resuspended in buffer A containing 25% glycerol to a final volume of 0.34 ml. Digestion with TPCK-treated trypsin was carried out as described under "Experimental Procedures." As control, Gt (0.54 mg) in solution was similarly treated with TPCK-treated trypsin. At the indicated time points, aliquots were removed from the incubation mixtures, and the reaction was stopped by adding TLCK to a final concentration of 40 µg/ml. The proteolytic fragments (~9 µg of Gt/lane) were separated by electrophoresis on SDS-polyacrylamide gels (12.5%) that were stained with Coomassie Blue. A, time course of Gt limited tryptic digestion; B, time course of Gt limited tryptic digestion in the presence of Rh*; C, time course of Gt limited tryptic digestion in the presence of Rh* plus GDPbeta S; D, time course of Gt limited tryptic digestion in the presence of Rh. Molecular weight standards are indicated, as are the size and the origin of the fragments. Gt, control at time 0.
[View Larger Version of this Image (62K GIF file)]


In the presence of urea-washed ROS membranes, the fragments originating from the cleavage of the beta t subunit were visible in the gels (Fig. 2). Although under all three conditions a small amount of beta 23 and beta 14 fragments was present during the time course, it appeared that there was less of each fragment throughout the time course (Fig. 2). This was different from the digestion time course of soluble Gt, in which the two fragments were generated immediately. Thus, it would appear that the presence of membranes of any kind partially protects the beta t subunit from tryptic cleavage at Arg129.

To examine the presence of alpha t fragments more clearly, immunoblotting with antipeptide antibodies of defined specificity was carried out. The anti-alpha t-(195-206) antiserum 8645 recognized several alpha t fragments, which were easily identifiable in the immunoblot (Fig. 3A), alpha 38, alpha 34, alpha 32, alpha 23, and alpha 21. In the presence of Rh*, the alpha t subunit was a very poor substrate for tryptic cleavage (Fig. 3B). The alpha 34 and alpha 32 fragments were not generated, while low amounts of alpha 23 and alpha 21 appeared very late in the time course. Similar experiments performed with monoclonal antibody 4A, which binds to the amino-terminal region of the alpha t subunit (29); antiserum 1398, which binds to the phosphate binding loop (34); and antiserum 116, which binds to the carboxyl-terminal region (35) confirmed that under conditions of high affinity interaction between Gt and Rh*, the three major tryptic sites on the alpha t subunit were protected from cleavage (data not shown).


Fig. 3. Identification of alpha t proteolytic fragments by immunoblot using anti-alpha t-(195-206) antiserum. Purified bovine Gt (0.55 mg) was incubated in 1 ml of buffer A with PL or urea-washed ROS membranes (36 µM Rh) in the dark or light for 10 min. The samples were centrifuged, and the pellets were resuspended in buffer A containing 25% glycerol to a final volume of 0.34 ml. Digestion with TPCK-treated trypsin was carried out as described under "Experimental Procedures." As control, Gt (0.54 mg) in solution was also treated with TPCK-treated trypsin. At the indicated time points, aliquots were removed from the incubation mixtures, and the reaction was stopped by adding TLCK to a final concentration of 40 µg/ml. The proteolytic fragments (~9 µg of Gt/lane) were separated by electrophoresis on SDS-polyacrylamide gels (12.5%) and blotted onto nitrocellulose. Antibody binding to alpha t subunit and fragments was detected as described under "Experimental Procedures." A, time course of alpha t limited tryptic digestion; B, time course of alpha t limited tryptic digestion in the presence of Rh*; C, time course of alpha t limited tryptic digestion in the presence of PL; D, time course of alpha t limited tryptic digestion in the presence of Rh. Molecular weight standards are indicated, as are the size and origin of the fragments. Gt, control at time 0.
[View Larger Version of this Image (65K GIF file)]


In the presence of ROS membranes that had not been light-activated, (Fig. 3D) or phospholipid vesicles (Fig. 3C), the time courses of limited tryptic digestion of the alpha t subunit were more similar to that obtained in the absence of membranes. However, the relative production of alpha 32 was lower in the presence of membranes or PL, probably due to protection of the cleavage site at Lys18. In addition, in the presence of Rh less alpha 34 was produced, suggesting a modest protection of Arg310, and the alpha 23 fragment was somewhat stabilized.

To quantitate the data, we analyzed the immunoblots by densitometry (Fig. 4). Both the disappearance of alpha t and the appearance of the alpha 34, alpha 32, and alpha 21 fragments were measured. Fig. 4 shows clearly that the alpha t subunit was protected in the presence of Rh*. This implies that all three major proteolytic sites of alpha t are protected when Gt is in high affinity interaction with Rh* (Table I).


Fig. 4. Quantitative analysis of alpha t subunit and proteolytic fragments detected using anti-alpha t-(195-206) antiserum. The density of the polypeptide bands was measured using a Molecular Dynamics densitometer. Each data point is expressed as the integrated area of the polypeptide band divided by the combined integrated areas of all bands present in the sample. Time courses of Gt (black-square), Gt + Rh* (black-triangle), Gt + Rh* + GDPbeta S (black-down-triangle ), Gt + Rh (black-diamond ), and Gt + PL (bullet ) limited tryptic digestion are shown. The presented results are the averages of two experiments. A, digestion rate of the alpha t subunit; B, production rate of the alpha 34 fragment; C, production rate of the alpha 32 fragment; D, production rate of the alpha 21 fragment.
[View Larger Version of this Image (22K GIF file)]


Table I.

Protected tryptic cleavage sites of the alpha 1 subunit by incubation of Gt with PL, Rh, or Rh*


Lys18 Arg264 Arg310

Gt +/-a  -  -
Gt + Rh* ++ ++ +++
Gt + Rh* + GDPbeta S ++ +/- +
Gt + Rh ++  - +/-
Gt + PL ++  -  -

a  +++, complete protection; ++, protection; +, mild protection; +/-, partial protection; -, no protection.

In the presence of PL, there was an increased generation of alpha 34 (Fig. 4B) and decreased generation of the alpha 32 fragment (Fig. 4C). This suggests that interaction of Gt with phospholipids leads to protection of the cleavage site at Lys18 (see also Fig. 5). In the presence of Rh, there was also a decreased production of the alpha 32 fragment (Fig. 4C) but no compensating increase of alpha 34 (Fig. 4B). In fact, there was a decreased production of the alpha 34 fragment. This suggests that Rh is capable of weakly protecting the cleavage site at Arg310. In the presence of either PL or Rh, the production of alpha 21 was increased with respect to Gt in solution (Fig. 4D). It thus appears that proteolytic cleavage at Arg204 is accelerated when Lys18 is protected.


Fig. 5. Quantitative analysis of the alpha 38 fragment produced during limited tryptic digestion of Gt in the presence and absence of phospholipid vesicles. Incubation of Gt with PL and proteolytic digestion with TPCK-treated trypsin were carried out as described under "Experimental Procedures." The proteolytic fragments were separated by electrophoresis on SDS-polyacrylamide gels (12.5%) that were stained with Coomassie Blue. The density of the stained bands was measured using a Molecular Dynamics densitometer. Each data point is expressed as the integrated area of the alpha 38 band divided by the combined integrated areas of all bands present in the sample. Time courses of Gt (black-square) and Gt + PL (bullet ) limited tryptic digestion are shown. The production rate of the alpha 38 fragment is shown. Coomassie Blue-stained gels are shown in the inset: time courses of Gt (A), and Gt + PL (B) limited tryptic digestion. Gt, control at time 0.
[View Larger Version of this Image (30K GIF file)]


GDPbeta S is known to reverse the high affinity state between Gt and Rh* (26, 27). The data (Fig. 4, Table I) show that the high affinity interaction with Rh* was needed for its protection of proteolytic sites on alpha t, because there was a partial reversal of the protection of Arg310 and Arg204. Comparison of the amounts of alpha 34 and alpha 32 shows that even in the low affinity state, the cleavage site at Lys18 was protected, consistent with the ability of PL or Rh to protect this site.

To examine in more detail the ability of phospholipids to protect the cleavage site at Lys18, we studied the appearance of the transient alpha 38 fragment in the presence or absence of PL. Fig. 5 shows that PL completely inhibited the production of the alpha 38 fragment. In addition, in the presence of PL, the formation of alpha 32 was decreased at the expense of an increased formation of the alpha 34 fragment.

Table I summarizes the findings, while the locations of the various cleavage sites on the Gt heterotrimer are shown in the stereoview in Fig. 6. It is interesting to note that all alpha t tryptic cleavage sites are located on the same side of the molecule (Fig. 6), in close proximity to the receptor, beta gamma t subunit, and effector binding regions. This observation may suggest that protein regions that are involved in protein-protein interaction are flexible.


Fig. 6. Stereo view of heterotrimeric Gt showing the tryptic cleavage sites on alpha t and beta t. The dark spheres denote residues that are available sites for tryptic hydrolysis.
[View Larger Version of this Image (38K GIF file)]



DISCUSSION

The studies described here provide insight into the regions of a G protein that bind to an activated receptor. The accessibility of Gt to tryptic proteolysis is changed dramatically when it is in high affinity interaction with Rh*. We have dissected the effects of phospholipids, ROS membranes containing inactive Rh, and the low affinity interaction of GDPbeta S-bound Gt with Rh* on the availability of the tryptic cleavage sites.

It is well known that heterotrimeric G proteins are membrane-associated even in the absence of activated receptors. This association is thought to be mediated mainly by interactions of fatty acyl and prenyl groups of alpha  and gamma  subunits with membranes (42, 43). All G protein alpha  subunits are modified at or near their amino termini by covalent attachment of the fatty acid myristate and/or palmitate, while the gamma  subunits are prenylated at a cysteine residue located in their carboxyl termini (43). The alpha t subunit is heterogenously modified at its amino terminus by myristate and three other less hydrophobic fatty acids (44, 45), but it does not contain palmitate. The presence of membranes is important for alpha t-beta gamma t subunit interaction (46), so it might be expected that their presence affects the proteolytic cleavage pattern of Gt. In fact, we found that both phospholipid vesicles and ROS membranes protect the cleavage site in the amino terminus of alpha t at Lys18.

Numerous biochemical (29, 31, 47, 48) and mutational (49, 50) studies have implicated the amino terminus of G protein alpha  subunits in the interaction with beta gamma subunits. The resolution of the crystal structure of heterotrimeric Gt (14) has confirmed that the amino-terminal helix of the alpha t subunit is involved in forming a binding site for the beta t subunit. Numerous potential proteolytic cleavage sites are located in this amino-terminal helix of alpha t (29). Navon and Fung (31) have shown that the presence of beta gamma t reduces the cleavage rate of the alpha t subunit at Glu21 by Staphylococcus aureus V8 protease. The chymotryptic cleavage sites at Leu15 and Leu19 are partially protected (51) by the presence of beta gamma t that directly contacts these residues (14). It is likely that in the heterotrimeric Gt the tryptic cleavage site at Lys18 is also partially protected. The presence of membranes of any kind determines an increase of the protection. The effect may be direct or the consequence of a conformational change of the amino-terminal alpha -helix of alpha t induced by the concomitant interaction with beta gamma t and membranes. Overall, the protection suggests that this region is in contact with the membrane, consistent with the crystal structure of the heterotrimer (14).

Our results indicate that in the presence of Rh* the alpha t subunit of heterotrimeric Gt is almost completely protected from tryptic hydrolysis. In particular, the cleavage site at Arg310 is not available for digestion. We cannot determine whether this protection is the consequence of Rh* binding to that region of alpha t or a change of alpha t conformation upon Rh* binding. However, the former possibility is in agreement with previous observations. Data reported by Hamm et al. (4) indicate that the alpha t residues 311-323 participate with the carboxyl-terminal residues 340-350 to form the binding site for Rh*. Resolution of the crystal structure of the alpha t subunit in the GTPgamma S and GDP-bound forms (8, 11) has shown that alpha t residues 320-323 (TCAT) contribute directly to nucleoside binding through a van der Waals contact with the guanine ring. A receptor-stimulated movement of alpha -helix 5 may allow for the release of GDP. Consistent with this suggestion, disturbing the interactions between the conserved TCAT region (beta 6-alpha 5 loop) of the alpha  subunit and the guanine ring of GDP has been shown to decrease GDP affinity (16, 17). The crystal structures of alpha t-GDP and heterotrimeric Gt also show that Arg310 is located in a surface-exposed loop, the alpha 4/beta 6 region, which is spatially close to the carboxyl-terminal residues, 340-350 (Fig. 6). The activated receptor could trigger the release of bound guanine nucleotide by interacting with this region in concert with the COOH-terminal region. Binding of GDPbeta S interacting through the guanine ring with the beta 6-alpha 5 loop could decrease the affinity of the alpha t subunit for Rh* via beta 6 or alpha 5. This effect is demonstrated here by the partial reversal of the protective effect of Rh* at Arg310 by GDPbeta S (Table I). Both guanine nucleoside diphosphate and triphosphate are able to modulate the interaction of the alpha t subunit with Rh* and cause Rh* decay as reported by several observations (26, 27). The mechanism of this communication between the Rh* and nucleotide binding sites is not known.

In the presence of dark-adapted rhodopsin, the alpha t cleavage site at Arg310 is not completely available for tryptic digestion as indicated by the production of lower amounts of the 34-kDa fragment. A larger amount of the fragment is generated when Gt is digested in the presence of phospholipid vesicles. These observations suggest that there is a low affinity interaction of this region with inactive Rh.

Our data also indicate that in the presence of Rh* another tryptic cleavage site of alpha t, Arg204, is less available to digestion. In the presence of GDPbeta S, the accessibility to this cleavage site is partially restored. Arg204 is located in the switch II region, residues 198-215 (8), and is protected from tryptic hydrolysis in the alpha t·GTPgamma S complex but not in the alpha t·GDP complex (28). The switch II region undergoes a distinct transition from a distorted helical structure with the Arg204 side chain in a solvent-exposed conformation when alpha t is in the GDP-bound form to a well ordered helix (alpha 2-helix) interacting with residues from the alpha 3-helix and switch III in the alpha t·GTPgamma S complex (9). Structural studies have shown that this region forms an important part of the beta gamma t contact interface (14) (Fig. 6). In the presence of Rh*, protection of the cleavage site of alpha t at Arg204 can result from a direct interaction of Rh* with this region or as a consequence of a conformational change induced by the activated receptor. Alternatively, Rh* can directly or indirectly cooperate with beta gamma t to determine this protection. In the presence of GDPbeta S, this protective effect is reduced. Thus, after release of GDP as a consequence of alpha t activation by Rh*, the binding affinity of the switch II region for beta gamma t may increase, and the accessibility of the protease to Arg204 is almost completely blocked. Our results suggest that in the "empty pocket" state the alpha t subunit forms a tight complex with beta gamma t and Rh*.

In conclusion, using limited tryptic digestion as an experimental approach, we have defined the regions of Gt involved in the interaction with the activated receptor. In the presence of Rh*, two major cleavage sites of the alpha t subunit, Arg204 and Arg310, are protected, while the cleavage rate at Lys18 is substantially decreased in the presence of either ROS membranes or PL.


FOOTNOTES

*   This work was supported by Grant EY 06062 from the National Institutes of Health (to H. E. H.). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   Recipient of a traveling grant from Council for International Exchange of Scholars under the Fulbright Program, and a Human Capital x Mobility grant from the European Community.
par    To whom correspondence should be addressed: Dept. of Physiology and Biophysics, University of Illinois at Chicago, 835 S. Wolcott, M/C 901, Chicago, IL 60612. Tel.: 312-996-7272; Fax: 312-996-1414.
1   The abbreviations used are: GTPgamma S, guanosine 5'-O-(thiotriphosphate); Gt, the G protein of rod outer segment, transducin; Gi1, a G protein coupled to the inhibition of adenylyl cyclase; Go, a G protein present predominantly in brain; alpha t and beta gamma t, the alpha  and beta gamma subunits of transducin; alpha o, the alpha  subunit of Go; ROS, rod outer segment; Rh, rhodopsin; Rh*, metarhodopsin II; PL, phospholipid vesicles; PC, phosphatidylcholine; GDPbeta S, guanyl-5'-yl thiophosphate; PBS, phosphate-buffered saline; TLCK, 1-chloro-3-tosylamido-7-amino-2-heptanone hydrochloride; TPCK, L-1-tosylamido-2-phenylethyl chloromethyl ketone; MOPS, 3-(N-morpholino)propanesulfonic acid.

Acknowledgments

We are grateful to Dr. D. Manning for providing the alpha  subunit antisera. We thank Dr. A. Gilchrist, Dr. N. Gill, and Dr. J. Malinski for helpful discussion.


REFERENCES

  1. Hargrave, P. A., Hamm, H. E., and Hofmann, K. P. (1993) BioEssays 15, 43-50 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  2. Hein, L., and Kobilka, B. K. (1995) Neuropharmacology 34, 357-366 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  3. Strader, C. D., Fong, T. M., Graziano, M. P., and Tota, M. R. (1995) FASEB J. 9, 745-754 [Medline] [Abstract]
  4. Hamm, H. E., Deretic, D., Arendt, A., Hargrave, P. A., Koenig, B., and Hofmann, K. P. (1988) Science 241, 832-835 [Medline] [Abstract/Free Full Text]
  5. Conklin, B. R., Farfel, Z., Lusting, K. D., Julius, D., and Bourne, H. R. (1993) Nature 363, 274-276 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  6. Lee, C. H., Katz, A., and Simon, M. I. (1995) Mol. Pharmacol. 47, 218-223 [Medline] [Abstract]
  7. Rens-Damiano, S., and Hamm, H. E. (1995) FASEB J. 9, 1059-1066 [Abstract]
  8. Noel, J. P., Hamm, H. E., and Sigler, P. B. (1993) Nature 366, 654-663 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  9. Sondek, J., Lambright, D. G., Noel, J. P., Hamm, H. E., and Sigler, P. B. (1994) Nature 372, 276-279 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  10. Coleman, D. E., Berghuis, A. M., Lee, E., Linder, M. E., Gilman, A. G., and Sprang, S. R. (1994) Science 265, 1405-1412 [Medline] [Abstract/Free Full Text]
  11. Lambright, D. G., Noel, J. P., Hamm, H. E., and Sigler, P. B. (1994) Nature 369, 621-628 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  12. Coleman, D. E., Lee, E., Mixon, M. B., Linder, M. E., Berghuis, A., Gilman, A. G., and Sprang, S. R. (1994) J. Mol. Biol. 238, 630-634 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  13. Wall, M. A., Coleman, D. E., Lee, E., Iñiguez-Lluhi, J. A., Posner, B. A., Gilman, A. G., and Sprang, S. R. (1995) Cell 83, 1047-1058 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  14. Lambright, D. G., Sondek, J., Bohm, A., Skiba, N. P., Hamm, H. E., and Sigler, P. B. (1996) Nature 379, 311-319 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  15. Denker, B. M., Schmidt, C. J., and Neer, E. J. (1992) J. Biol. Chem. 267, 9998-10002 [Medline] [Abstract/Free Full Text]
  16. Garcia, P. D., Onrust, R., Bell, S. M., Sakamar, T. P., and Bourne, H. R. (1995) EMBO J. 14, 4460-4469 [Medline] [Medline] [Order article via Infotrieve]
  17. Thomas, T. C., Schmidt, C. J., and Neer, E. J. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 10295-10299 [Medline] [Abstract/Free Full Text]
  18. Iyengar, R., Abramowitz, J., Bordelon-Riser, M., Blume, A. J., and Birnbaumer, L. (1980) J. Biol. Chem. 255, 10312-10321 [Medline] [Abstract/Free Full Text]
  19. Rojas, F. J., and Birnbaumer, L. (1985) J. Biol. Chem. 260, 7829-7835 [Medline] [Abstract/Free Full Text]
  20. Kühn, H. (1980) Nature 283, 587-589 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  21. Emeis, D., Kühn, H., Reichert, J., and Hofmann, K. P. (1982) FEBS Lett. 143, 29-34 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  22. Pfister, C., Kühn, H., and Chabre, M. (1983) Eur. J. Biochem. 136, 489-499 [Medline] [Medline] [Order article via Infotrieve]
  23. Bournaucin, F., Pfister, C., and Chabre, M. (1989) Eur. J. Biochem. 184, 687-698 [Medline] [Order article via Infotrieve]
  24. Stryer, L., Hurley, J. B., and Fung, B. K.-K. (1983) Methods Enzymol. 96, 617-627 [Medline] [Medline] [Order article via Infotrieve]
  25. Hamm, H. E. (1990) in The Biology and Medicine of Signal Transduction (Nishizuka, Y., Endo, M., and Tanaka, C., eds), pp. 76-82, Raven Press, New York
  26. Kahlert, M., Koning, B., and Hofmann, K. P. (1990) J. Biol. Chem. 265, 18928-18932 [Medline] [Abstract/Free Full Text]
  27. Panico, J., Parkes, J. H., and Liebman, P. A. (1990) J. Biol. Chem. 265, 18922-18927 [Medline] [Abstract/Free Full Text]
  28. Fung, B. K.-K., and Nash, C. R. (1983) J. Biol. Chem. 258, 10503-10510 [Abstract/Free Full Text]
  29. Mazzoni, M. R., Malinski, J. A., and Hamm, H. E. (1991) J. Biol. Chem. 266, 14072-14081 [Medline] [Abstract/Free Full Text]
  30. Hurley, J. B., Simon, M. L., Teplow, D. B., Robishaw, J. D., and Gilman, A. G. (1984) Science 226, 860-862 [Medline] [Abstract/Free Full Text]
  31. Navon, S. E., and Fung, B. K.-K. (1987) J. Biol. Chem. 262, 15746-15751 [Medline] [Abstract/Free Full Text]
  32. Hamm, H. E., and Bownds, M. D. (1984) J. Gen. Physiol. 84, 265-280 [Medline] [Abstract/Free Full Text]
  33. Witt, P. L., Hamm, H. E., and Bownds, M. D. (1984) J. Gen. Physiol. 84, 251-263 [Medline] [Abstract/Free Full Text]
  34. Carlson, K. E., Brass, L. F., and Manning, D. R. (1989) J. Biol. Chem. 264, 13298-13305 [Medline] [Abstract/Free Full Text]
  35. Skiba, N. P., Bae, H., and Hamm, H. E. (1996) J. Biol. Chem. 271, 413-424 [JBC][Medline] [Abstract/Free Full Text]
  36. Laemmli, U. K. (1970) Nature 227, 680-685 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  37. Towbin, H., Staehelin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354 [Medline] [Abstract/Free Full Text]
  38. Kim, J., Blackshear, P. J., Johnson, J. D., and McLaughlin, S. (1994) Biophys. J. 67, 227-237 [Medline] [Medline] [Order article via Infotrieve]
  39. Malinski, J. A., and Wensel, T. G. (1992) Biochemistry 31, 9502-9512 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  40. Yamanaka, G., Eckstein, F., and Stryer, L. (1985) Biochemistry 24, 8094-8101 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  41. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  42. Yamane, H. K., and Fung, B. K.-K. (1993) Annu. Rev. Pharmacol. Toxicol. 32, 201-241 [CrossRef]
  43. Wedegaertner, P. B., Wilson, P. T., and Bourne, H. R. (1995) J. Biol. Chem. 270, 503-506 [JBC][Medline] [Free Full Text]
  44. Kokame, K., Fukada, Y., Yoshizawa, T., Takao, T., and Shimonishi, Y. (1992) Nature 359, 749-752 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  45. Neubert, T. A., Johnson, R. S., Hurley, J. B., and Walsh, K. A. (1992) J. Biol. Chem. 267, 18274-18277 [Medline] [Abstract/Free Full Text]
  46. Bigay, J., Faurobert, E., Franco, M., and Chabre, M. (1994) Biochemistry 33, 14081-14090 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  47. Mazzoni, M. R., and Hamm, H. E. (1989) Biochemistry 28, 9873-9880 [Medline] [CrossRef][Medline] [Order article via Infotrieve]
  48. Neer, E. J., Pulsifer, L., and Wolf, L. G. (1988) J. Biol. Chem. 263, 8996-9000 [Medline] [Abstract/Free Full Text]
  49. Graf, R., Mattera, R., Codina, J., Estes, M. K., and Birnbaumer, L. (1992) J. Biol. Chem. 267, 24307-24314 [Medline] [Abstract/Free Full Text]
  50. Denker, B. M., Neer, E. J., and Schmidt, C. J. (1992) J. Biol. Chem. 267, 6272-6277 [Medline] [Abstract/Free Full Text]
  51. Mazzoni, M. R., and Hamm, H. E. (1993) J. Protein Chem. 12, 215-221 [Medline] [CrossRef][Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
A. Heydorn, R. J. Ward, R. Jorgensen, M. M. Rosenkilde, T. M. Frimurer, G. Milligan, and E. Kostenis
Identification of a Novel Site within G Protein {alpha} Subunits Important for Specificity of Receptor-G Protein Interaction
Mol. Pharmacol., August 1, 2004; 66(2): 250 - 259.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
T. M. Cabrera-Vera, J. Vanhauwe, T. O. Thomas, M. Medkova, A. Preininger, M. R. Mazzoni, and H. E. Hamm
Insights into G Protein Structure, Function, and Regulation
Endocr. Rev., December 1, 2003; 24(6): 765 - 781.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Havlickova, J. Blahos, I. Brabet, J. Liu, B. Hruskova, L. Prezeau, and J.-P. Pin
The Second Intracellular Loop of Metabotropic Glutamate Receptors Recognizes C Termini of G-protein {alpha}-Subunits
J. Biol. Chem., September 12, 2003; 278(37): 35063 - 35070.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Cai, Y. Itoh, and H. G. Khorana
From the Cover: Mapping of contact sites in complex formation between transducin and light-activated rhodopsin by covalent crosslinking: Use of a photoactivatable reagent
PNAS, April 24, 2001; 98(9): 4877 - 4882.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. R. Mazzoni, S. Taddei, L. Giusti, P. Rovero, C. Galoppini, A. D'Ursi, S. Albrizio, A. Triolo, E. Novellino, G. Greco, et al.
A Galpha s Carboxyl-Terminal Peptide Prevents Gs Activation by the A2A Adenosine Receptor
Mol. Pharmacol., July 1, 2000; 58(1): 226 - 236.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. Bae, T. M. Cabrera-Vera, K. M. Depree, S. G. Graber, and H. E. Hamm
Two Amino Acids within the alpha 4 Helix of Galpha i1 Mediate Coupling with 5-Hydroxytryptamine1B Receptors
J. Biol. Chem., May 21, 1999; 274(21): 14963 - 14971.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
K. Kitamura, N. Shiraishi, W. D. Singer, M. E. Handlogten, K. Tomita, and R. T. Miller
Endothelin-B receptors activate Galpha 13
Am J Physiol Cell Physiol, April 1, 1999; 276(4): C930 - C937.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Natochin, A. E. Granovsky, K. G. Muradov, and N. O. Artemyev
Roles of the Transducin alpha -Subunit alpha 4-Helix/alpha 4-beta 6 Loop in the Receptor and Effector Interactions
J. Biol. Chem., March 19, 1999; 274(12): 7865 - 7869.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Gilchrist, M. R. Mazzoni, B. Dineen, A. Dice, J. Linden, W. R. Proctor, C. R. Lupica, T. V. Dunwiddie, and H. E. Hamm
Antagonists of the Receptor-G Protein Interface Block Gi-coupled Signal Transduction
J. Biol. Chem., June 12, 1998; 273(24): 14912 - 14919.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. E. Hamm
The Many Faces of G Protein Signaling
J. Biol. Chem., January 9, 1998; 273(2): 669 - 672.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Bae, K. Anderson, L. A. Flood, N. P. Skiba, H. E. Hamm, and S. G. Graber
Molecular Determinants of Selectivity in 5-Hydroxytryptamine1B Receptor-G Protein Interactions
J. Biol. Chem., December 19, 1997; 272(51): 32071 - 32077.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Aris, A. Gilchrist, S. Rens-Domiano, C. Meyer, P. J. Schatz, E. A. Dratz, and H. E. Hamm
Structural Requirements for the Stabilization of Metarhodopsin II by the C Terminus of the alpha subunit of Transducin
J. Biol. Chem., January 19, 2001; 276(4): 2333 - 2339.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Blahos, T. Fischer, I. Brabet, D. Stauffer, G. Rovelli, J. Bockaert, and J.-P. Pin
A Novel Site on the Galpha -protein That Recognizes Heptahelical Receptors
J. Biol. Chem., January 26, 2001; 276(5): 3262 - 3269.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. P. Marin, A. G. Krishna, V. Archambault, E. Simuni, W.-Y. Fu, and T. P. Sakmar
The Function of Interdomain Interactions in Controlling Nucleotide Exchange Rates in Transducin
J. Biol. Chem., June 22, 2001; 276(26): 23873 - 23880.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mazzoni, M. R.
Right arrow Articles by Hamm, H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mazzoni, M. R.
Right arrow Articles by Hamm, H. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement